Article
Orexin-A Reverse Bone Mass Loss Induced by Chronic Intermittent Hypoxia Through…
Drug Design, Development and Therapy · 2022 · Gu H, Ru Y, Wang W, Cai G, Gu L, Ye J, Zhang WB, Wang L
Key facts
| Title | Orexin-A Reverse Bone Mass Loss Induced by Chronic Intermittent Hypoxia Through OX1R-Nrf2/HIF-1α Pathway |
|---|---|
| First author | Gu H, Ru Y, Wang W, Cai G, Gu L, Ye J, Zhang WB, Wang L |
| Journal | Drug Design, Development and Therapy |
| Published | Jul 5, 2022 |
| DOI | 10.2147/DDDT.S363286 |
| Devices mentioned | 215000, K071580 |
| Product codes mentioned | CIT, GIA, JCJ |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1